Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
fsp peptides (1 trial)
h-1pv (1 trial)
p16_37-63 (1 trial)
parvovirus h-1 (1 trial)
montanide isa51 (1 trial)
p16_37-63 peptide (1 trial)
Carcinoma, Pancreatic Ductal (Phase 2)
Colorectal Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Trials (5 total)
Trial APIs (6 total)